009420.KS
Hanall Biopharma Co.,Ltd
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 48,150.00
+0.84%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 897.36x
- P/E 2028E
- 451.44x
- P/S forward
- 23.08x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 15.56x
- Price / sales
- 15.46x
- Price / cash flow
- -2024.46x
Enterprise value
- Enterprise value
- KRW 2.53T
- EV / sales
- 15.56x
- EV / EBITDA
- -186.88x
- EV / EBIT
- 644.81x
- Market cap
- KRW 2.52T
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026